Loading...

AgeX Therapeutics, Inc.

AGE•AMEX
Healthcare
Biotechnology
$11.10
$-1.50(-11.90%)

AgeX Therapeutics, Inc. (AGE) Stock Chart & Performance Analysis

Explore AgeX Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-14.81%
3-Month Change
-21.50%
6-Month Change
-52.85%
Year-to-Date (YTD) Change
-24.64%
1-Year Change
-51.82%
3-Year Change
-79.77%
5-Year Change
-93.28%
All-Time (Max) Change
-88.35%

Analyzing AgeX Therapeutics, Inc. (AGE) Trends Across Multiple Time Frames

AgeX Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. AgeX Therapeutics, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a -14.81% drop could signal a pullback, whereas a 3-month decline of -21.50% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -52.85% and a YTD drop of -24.64% might concern investors, but a 1-year loss of -51.82% and a 3-year drop of -79.77% could indicate resilience. The 5-year surge of -93.28% highlights weak historical growth, while the all-time return of -88.35% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;